Trial
NCT05712356
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Lisata Therapeutics, Inc.
Collaborators
—
Condition
Cholangiocarcinoma
Intervention
certepetide
Why stopped
The study was halted prematurely to allow analysis of the results.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-26